BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kalil AC, Thomas PG. Influenza virus-related critical illness: pathophysiology and epidemiology. Crit Care 2019;23:258. [PMID: 31324202 DOI: 10.1186/s13054-019-2539-x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 132] [Article Influence: 29.7] [Reference Citation Analysis]
Number Citing Articles
1 Song J, Zhao J, Cai X, Qin S, Chen Z, Huang X, Li R, Wang Y, Wang X. Lianhuaqingwen capsule inhibits non-lethal doses of influenza virus-induced secondary Staphylococcus aureus infection in mice. J Ethnopharmacol 2022;298:115653. [PMID: 35995276 DOI: 10.1016/j.jep.2022.115653] [Reference Citation Analysis]
2 Latha K, Rao S, Sakamoto K, Watford WT. Tumor Progression Locus 2 Protects against Acute Respiratory Distress Syndrome in Influenza A Virus-Infected Mice. Microbiol Spectr 2022;:e0113622. [PMID: 35980186 DOI: 10.1128/spectrum.01136-22] [Reference Citation Analysis]
3 Radovanovic M, Dumic I, Nordstrom CW, Hanna RD. Fulminant Influenza a Myocarditis Complicated by Transient Ventricular Wall Thickening and Cardiac Tamponade. Infectious Disease Reports 2022;14:600-8. [DOI: 10.3390/idr14040065] [Reference Citation Analysis]
4 Liu M, Liu T, Wang X, Yu C, Qin T, Li J, Zhang M, Li Z, Cui X, Xu X, Liu Q. Cangma Huadu granules attenuate H1N1 virus-induced severe lung injury correlated with repressed apoptosis and altered gut microbiome. Front Microbiol 2022;13:947112. [DOI: 10.3389/fmicb.2022.947112] [Reference Citation Analysis]
5 Biasco L, Valotta A, Klersy C, Valgimigli M, Gabutti L, Bruna RD, Pagnamenta A, Ruinelli L, Senatore G, Pedrazzini GB. Association among myocardial injury and mortality in Influenza: A prospective cohort study. International Journal of Cardiology 2022. [DOI: 10.1016/j.ijcard.2022.08.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wang Y, Limaye A, Liu J, Wu T. Potential probiotics for regulation of the gut-lung axis to prevent or alleviate influenza in vulnerable populations. Journal of Traditional and Complementary Medicine 2022. [DOI: 10.1016/j.jtcme.2022.08.004] [Reference Citation Analysis]
7 Torrecillas M, Gumucio VD, Padullés A, Tubau F, Marco D, Shaw E, Fernández-huerta M, Maisterra K, Grau I, Petito MM, Berbel D, Puig-asensio M, Pérez XL, Domínguez MÁ, Sabater J, Ardanuy C, Càmara J. Antimicrobial use and aetiology of bloodstream infections in critically ill patients during early stages of SARS-CoV-2 pandemic. Infection Prevention in Practice 2022. [DOI: 10.1016/j.infpip.2022.100241] [Reference Citation Analysis]
8 Wallick C, To TM, Korom S, Masters H 3rd, Hanania NA, Moawad D. Impact of influenza infection on the short- and long-term health of patients with chronic obstructive pulmonary disease. J Med Econ 2022;:1-29. [PMID: 35837794 DOI: 10.1080/13696998.2022.2098630] [Reference Citation Analysis]
9 Radovanovic M, Petrovic M, Barsoum MK, Nordstrom CW, Calvin AD, Dumic I, Jevtic D, Hanna RD. Influenza Myopericarditis and Pericarditis: A Literature Review. J Clin Med 2022;11:4123. [PMID: 35887887 DOI: 10.3390/jcm11144123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Faist A, Janowski J, Kumar S, Hinse S, Çalışkan DM, Lange J, Ludwig S, Brunotte L. Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond. Cells 2022;11:2198. [DOI: 10.3390/cells11142198] [Reference Citation Analysis]
11 Serrano GE, Walker JE, Tremblay C, Piras IS, Huentelman MJ, Belden CM, Goldfarb D, Shprecher D, Atri A, Adler CH, Shill HA, Driver-Dunckley E, Mehta SH, Caselli R, Woodruff BK, Haarer CF, Ruhlen T, Torres M, Nguyen S, Schmitt D, Rapscak SZ, Bime C, Peters JL, Alevritis E, Arce RA, Glass MJ, Vargas D, Sue LI, Intorcia AJ, Nelson CM, Oliver J, Russell A, Suszczewicz KE, Borja CI, Cline MP, Hemmingsen SJ, Qiji S, Hobgood HM, Mizgerd JP, Sahoo MK, Zhang H, Solis D, Montine TJ, Berry GJ, Reiman EM, Röltgen K, Boyd SD, Pinsky BA, Zehnder JL, Talbot P, Desforges M, DeTure M, Dickson DW, Beach TG. SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19. J Neuropathol Exp Neurol 2022:nlac056. [PMID: 35818336 DOI: 10.1093/jnen/nlac056] [Reference Citation Analysis]
12 Jin Z, Sheng H, Wang S, Wang Y, Cheng Y. Network pharmacology study to reveal active compounds of Qinggan Yin formula against pulmonary inflammation by inhibiting MAPK activation. J Ethnopharmacol 2022;:115513. [PMID: 35779819 DOI: 10.1016/j.jep.2022.115513] [Reference Citation Analysis]
13 Whitlock F, Murcia PR, Newton JR. A Review on Equine Influenza from a Human Influenza Perspective. Viruses 2022;14:1312. [PMID: 35746783 DOI: 10.3390/v14061312] [Reference Citation Analysis]
14 Fratty IS, Reznik-balter S, Nemet I, Atari N, Kliker L, Sherbany H, Keller N, Stein M, Mendelson E, Mandelboim M. Outbreak of Influenza and Other Respiratory Viruses in Hospitalized Patients Alongside the SARS-CoV-2 Pandemic. Front Microbiol 2022;13:902476. [DOI: 10.3389/fmicb.2022.902476] [Reference Citation Analysis]
15 Tran C, Pham T, Chichirelo-konstantynovych KD, Konstantynovych TV, Alif SM. Efficacy of maternal vaccination during pregnancy against infant respiratory viruses. Breathe 2022;18:220017. [DOI: 10.1183/20734735.0017-2022] [Reference Citation Analysis]
16 Bohmwald K, Andrade CA, Mora VP, Muñoz JT, Ramírez R, Rojas MF, Kalergis AM. Neurotrophin Signaling Impairment by Viral Infections in the Central Nervous System. Int J Mol Sci 2022;23:5817. [PMID: 35628626 DOI: 10.3390/ijms23105817] [Reference Citation Analysis]
17 Lee I, Chen Y, Huang C, Hsu J, Chang Y, Kuo H, Tai C, Lee N. A multicenter cohort study of severe dengue and critically ill influenza patients with elevated cardiac troponin-I: Difference clinical features and high mortality. Travel Medicine and Infectious Disease 2022;47:102281. [DOI: 10.1016/j.tmaid.2022.102281] [Reference Citation Analysis]
18 Fisher KL, Rajkumar-bhugeloo K, Moodley D, Mpotje T, Ramsuran D, Ndung'u T, Marakalala MJ. Investigating neutrophil cell death in TB pathogenesis. Gates Open Res 2021;5:175. [DOI: 10.12688/gatesopenres.13472.2] [Reference Citation Analysis]
19 Lin HY, Zeng YT, Lin CJ, Harroun SG, Anand A, Chang L, Wu CJ, Lin HJ, Huang CC. Partial carbonization of quercetin boosts the antiviral activity against H1N1 influenza A virus. J Colloid Interface Sci 2022;622:481-93. [PMID: 35525149 DOI: 10.1016/j.jcis.2022.04.124] [Reference Citation Analysis]
20 Wu J, Yonezawa T, Kishino H. Molecular Evolutionary Rate Predicts Intraspecific Genetic Polymorphism and Species-Specific Selection. Genes (Basel) 2022;13:708. [PMID: 35456514 DOI: 10.3390/genes13040708] [Reference Citation Analysis]
21 Bai H, Si L, Jiang A, Belgur C, Zhai Y, Plebani R, Oh CY, Rodas M, Patil A, Nurani A, Gilpin SE, Powers RK, Goyal G, Prantil-Baun R, Ingber DE. Mechanical control of innate immune responses against viral infection revealed in a human lung alveolus chip. Nat Commun 2022;13:1928. [PMID: 35396513 DOI: 10.1038/s41467-022-29562-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Loke MF, Yadav I, Lim TK, van der Maarel JRC, Sham LT, Chow VT. SARS-CoV-2 Spike Protein and Mouse Coronavirus Inhibit Biofilm Formation by Streptococcus pneumoniae and Staphylococcus aureus. Int J Mol Sci 2022;23:3291. [PMID: 35328711 DOI: 10.3390/ijms23063291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Kori A, Ratageri VH, Mithra CAG. Influenza and Covid-19 in Children: Time to Have a Close Watch! Indian J Pediatr 2022. [PMID: 35275340 DOI: 10.1007/s12098-022-04139-7] [Reference Citation Analysis]
24 Wieczfinska J, Kleniewska P, Pawliczak R, Kouretas D. Oxidative Stress-Related Mechanisms in SARS-CoV-2 Infections. Oxidative Medicine and Cellular Longevity 2022;2022:1-15. [DOI: 10.1155/2022/5589089] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
25 Hu Y, Pan Q, Zhou K, Ling Y, Wang H, Li Y. RUNX1 inhibits the antiviral immune response against influenza A virus through attenuating type I interferon signaling. Virol J 2022;19. [DOI: 10.1186/s12985-022-01764-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Mtambo SE, Ugbaja SC, Mushebenge AG, Abubakar BH, Ntuli ML, Kumalo HM. Intermolecular Mechanism and Dynamic Investigation of Avian Influenza H7N9 Virus' Susceptibility to E119V-Substituted Peramivir-Neuraminidase Complex. Molecules 2022;27:1640. [PMID: 35268741 DOI: 10.3390/molecules27051640] [Reference Citation Analysis]
27 Wu Z, Zhang R, Liu D, Liu X, Zhang J, Zhang Z, Chen S, He W, Li Y, Xu Y, Liu X. Acute Respiratory Distress Syndrome Caused by Human Adenovirus in Adults: A Prospective Observational Study in Guangdong, China. Front Med 2022;8:791163. [DOI: 10.3389/fmed.2021.791163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Valenzuela-Méndez B, Valenzuela-Sánchez F, Rodríguez-Gutiérrez JF, Bohollo-de-Austria R, Estella Á, Martínez-García P, González-García MÁ, Rello J. Plasma Levels of Mid-Regional Proadrenomedullin Accurately Identify H1N1pdm09 Influenza Virus Patients with Risk of Intensive Care Admission and Mortality in the Emergency Department. J Pers Med 2022;12:84. [PMID: 35055399 DOI: 10.3390/jpm12010084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Huang X, Lu F, Tian H, Hu H, Ning F, Shang Q, Hao D, Zhu W, Kong G, Ma X, Feng J, Wang T, Wang X. Association between plasma glycocalyx component levels and poor prognosis in severe influenza type A (H1N1). Sci Rep 2022;12:163. [PMID: 34997090 DOI: 10.1038/s41598-021-04146-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Benjamanukul S, Chansaenroj J, Chirathaworn C, Poovorawan Y. Atypical skin manifestation in severe acute chikungunya infection in a pregnant woman: a case report. J Med Case Rep 2022;16:5. [PMID: 34986884 DOI: 10.1186/s13256-021-03197-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Drăgănescu AC, Miron VD, Streinu-Cercel A, Florea D, Vlaicu O, Bilaşco A, Oţelea D, Luminos ML, Piţigoi D, Streinu-Cercel A, Săndulescu O. Circulation of influenza A viruses among patients hospitalized for severe acute respiratory infection in a tertiary care hospital in Romania in the 2018/19 season: Results from an observational descriptive epidemiological study. Medicine (Baltimore) 2021;100:e28460. [PMID: 34967388 DOI: 10.1097/MD.0000000000028460] [Reference Citation Analysis]
32 O'Driscoll LS, Martin-Loeches I. Management of Severe Influenza. Semin Respir Crit Care Med 2021;42:771-87. [PMID: 34918320 DOI: 10.1055/s-0041-1735491] [Reference Citation Analysis]
33 Nishioka K, Daidoji T, Nakaya T. Downregulation of calcium-regulated heat stable protein 1 expression by low-temperature stimulation causes reduction of interferon-β expression and sensitivity to influenza viral infection. Virus Res 2021;309:198659. [PMID: 34929215 DOI: 10.1016/j.virusres.2021.198659] [Reference Citation Analysis]
34 Chavez J, Hai R. Effects of Cigarette Smoking on Influenza Virus/Host Interplay. Pathogens 2021;10:1636. [DOI: 10.3390/pathogens10121636] [Reference Citation Analysis]
35 Fisher KL, Rajkumar-bhugeloo K, Moodley D, Mpotje T, Ramsuran D, Ndung'u T, Marakalala MJ. Investigating neutrophil cell death in TB pathogenesis. Gates Open Res 2021;5:175. [DOI: 10.12688/gatesopenres.13472.1] [Reference Citation Analysis]
36 Gunther RC, Bharathi V, Miles SD, Tumey LR, Schmedes CM, Tatsumi K, Bridges MD, Martinez D, Montgomery SA, Beck MA, Camerer E, Mackman N, Antoniak S. Myeloid Protease-Activated Receptor-2 Contributes to Influenza A Virus Pathology in Mice. Front Immunol 2021;12:791017. [DOI: 10.3389/fimmu.2021.791017] [Reference Citation Analysis]
37 Fakhri S, Mohammadi Pour P, Piri S, Farzaei MH, Echeverría J. Modulating Neurological Complications of Emerging Infectious Diseases: Mechanistic Approaches to Candidate Phytochemicals. Front Pharmacol 2021;12:742146. [PMID: 34764869 DOI: 10.3389/fphar.2021.742146] [Reference Citation Analysis]
38 Kim SY, Kim JH, Kim M, Wee JH, Jung Y, Min C, Yoo DM, Sim S, Choi HG. The associations of previous influenza/upper respiratory infection with COVID-19 susceptibility/morbidity/mortality: a nationwide cohort study in South Korea. Sci Rep 2021;11:21568. [PMID: 34732751 DOI: 10.1038/s41598-021-00428-x] [Reference Citation Analysis]
39 Karolyi M, Pawelka E, Kelani H, Funk GC, Lindner B, Porpaczy C, Publig S, Omid S, Seitz T, Traugott M, Turner M, Zoufaly A, Wenisch C. Management of hospitalized influenza A patients during the season 2018/19 : Comparison of three medical departments and the effect on outcome and antibiotic usage. Wien Klin Wochenschr 2021. [PMID: 34613478 DOI: 10.1007/s00508-021-01950-8] [Reference Citation Analysis]
40 Perry MA. Understanding influenza and the complications it causes. British Journal of Neuroscience Nursing 2021;17:183-6. [DOI: 10.12968/bjnn.2021.17.5.183] [Reference Citation Analysis]
41 Oakley S, Bouchet J, Costello P, Parker J. Influenza vaccine uptake among at-risk adults (aged 16-64 years) in the UK: a retrospective database analysis. BMC Public Health 2021;21:1734. [PMID: 34560879 DOI: 10.1186/s12889-021-11736-2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
42 Bouzid D, Casalino E, Mullaert J, Laurent O, Duval X, Lescure FX, Peiffer Smadja N, Tubiana S, Armand Lefèvre L, Descamps D, Fidouh N, Choquet C, Lucet JC, Visseaux B. Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial. J Antimicrob Chemother 2021;76:iii20-7. [PMID: 34555158 DOI: 10.1093/jac/dkab241] [Reference Citation Analysis]
43 Darling AJ, Federspiel JJ, Wein LE, Swamy GK, Dotters-Katz SK. Morbidity of late-season influenza during pregnancy. Am J Obstet Gynecol MFM 2021;4:100487. [PMID: 34543750 DOI: 10.1016/j.ajogmf.2021.100487] [Reference Citation Analysis]
44 Smiechowicz J, Barteczko-Grajek B, Adamik B, Bojko J, Gozdzik W, Lipinska-Gediga M. Influenza in patients with respiratory failure admitted to intensive care units in Poland and the use of extracorporeal respiratory support: a survey-based multicenter study. BMC Infect Dis 2021;21:954. [PMID: 34525950 DOI: 10.1186/s12879-021-06672-w] [Reference Citation Analysis]
45 Kim SK, Kim YH, Park S, Cho SW. Organoid engineering with microfluidics and biomaterials for liver, lung disease, and cancer modeling. Acta Biomater 2021;132:37-51. [PMID: 33711526 DOI: 10.1016/j.actbio.2021.03.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
46 Biasco L, Klersy C, Beretta GS, Valgimigli M, Valotta A, Gabutti L, Bruna RD, Pagnamenta A, Tersalvi G, Ruinelli L, Artero A, Senatore G, Jüni P, Pedrazzini GB, Bäck M. Comparative frequency and prognostic impact of myocardial injury in hospitalized patients with COVID-19 and Influenza. European Heart Journal Open 2021;1:oeab025. [DOI: 10.1093/ehjopen/oeab025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Liu S, Shen H, Huang S, Liu R, Qu D. First case of low-dose umbilical cord blood therapy for pediatric acute respiratory distress syndrome induced by Pneumocystis carinii pneumonia. Eur J Med Res 2021;26:100. [PMID: 34454624 DOI: 10.1186/s40001-021-00548-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Protonotarios A, Marelli-Berg F. Influenza-associated cardiac injury: a disease of the cardiac conduction system? Cardiovasc Res 2021;117:643-4. [PMID: 32556092 DOI: 10.1093/cvr/cvaa174] [Reference Citation Analysis]
49 Sencio V, Gallerand A, Gomes Machado M, Deruyter L, Heumel S, Soulard D, Barthelemy J, Cuinat C, Vieira AT, Barthelemy A, Tavares LP, Guinamard R, Ivanov S, Grangette C, Teixeira MM, Foligné B, Wolowczuk I, Le Goffic R, Thomas M, Trottein F. Influenza Virus Infection Impairs the Gut's Barrier Properties and Favors Secondary Enteric Bacterial Infection through Reduced Production of Short-Chain Fatty Acids. Infect Immun 2021;89:e0073420. [PMID: 33820816 DOI: 10.1128/IAI.00734-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
50 Verma AK, Bauer C, Palani S, Metzger DW, Sun K. IFN-γ Drives TNF-α Hyperproduction and Lethal Lung Inflammation during Antibiotic Treatment of Postinfluenza Staphylococcus aureus Pneumonia. J Immunol 2021;207:1371-6. [PMID: 34380647 DOI: 10.4049/jimmunol.2100328] [Reference Citation Analysis]
51 Blazoski CM, Baram M, Yang Q, Hirose H. Outcomes of extracorporeal membrane oxygenation in influenza versus COVID-19 during the first wave of COVID-19. J Card Surg 2021. [PMID: 34369601 DOI: 10.1111/jocs.15888] [Reference Citation Analysis]
52 Foessleitner P, Hoetzenecker K, Benazzo A, Klebermass-Schrehof K, Scharrer A, Kiss H, Farr A. Bilateral lung transplantation during pregnancy after ECMO for influenza-A caused ARDS. Am J Transplant 2021. [PMID: 34331831 DOI: 10.1111/ajt.16781] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Drake TM, Riad AM, Fairfield CJ, Egan C, Knight SR, Pius R, Hardwick HE, Norman L, Shaw CA, McLean KA, Thompson AAR, Ho A, Swann OV, Sullivan M, Soares F, Holden KA, Merson L, Plotkin D, Sigfrid L, de Silva TI, Girvan M, Jackson C, Russell CD, Dunning J, Solomon T, Carson G, Olliaro P, Nguyen-Van-Tam JS, Turtle L, Docherty AB, Openshaw PJ, Baillie JK, Harrison EM, Semple MG; ISARIC4C investigators. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. Lancet 2021;398:223-37. [PMID: 34274064 DOI: 10.1016/S0140-6736(21)00799-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
54 Yang B, Yang KD. Immunopathogenesis of Different Emerging Viral Infections: Evasion, Fatal Mechanism, and Prevention. Front Immunol 2021;12:690976. [PMID: 34335596 DOI: 10.3389/fimmu.2021.690976] [Reference Citation Analysis]
55 Feng J, Liu L, He Y, Wang M, Zhou D, Wang J. Novel insights into the pathogenesis of virus-induced ARDS: review on the central role of the epithelial-endothelial barrier. Expert Rev Clin Immunol 2021;:1-11. [PMID: 34224287 DOI: 10.1080/1744666X.2021.1951233] [Reference Citation Analysis]
56 Pedrina J, Stambas J. Targeting the Host Response: Can We Manipulate Extracellular Matrix Metalloproteinase Activity to Improve Influenza Virus Infection Outcomes? Front Mol Biosci 2021;8:703456. [PMID: 34291090 DOI: 10.3389/fmolb.2021.703456] [Reference Citation Analysis]
57 Conte C. Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4. Int J Mol Sci 2021;22:7135. [PMID: 34281186 DOI: 10.3390/ijms22137135] [Reference Citation Analysis]
58 Chan Y, Ng SW, Singh SK, Gulati M, Gupta G, Chaudhary SK, Hing GB, Collet T, MacLoughlin R, Löbenberg R, Oliver BG, Chellappan DK, Dua K. Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective. Life Sci 2021;280:119744. [PMID: 34174324 DOI: 10.1016/j.lfs.2021.119744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Proaños NJ, Reyes LF, Bastidas A, Martín-Loeches I, Díaz E, Suberviola B, Moreno G, Bodí M, Nieto M, Estella A, Sole-Violán J, Curcio D, Papiol E, Guardiola J, Rodríguez A; on behalf GETGAG SEMICYUC Working Group. Prior influenza vaccine is not a risk factor for bacterial coinfection in patients admitted to the ICU due to severe influenza. Med Intensiva 2021:S0210-5691(21)00118-2. [PMID: 34175139 DOI: 10.1016/j.medin.2021.05.013] [Reference Citation Analysis]
60 Land WG. Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome-with a preliminary reference to SARS-CoV-2 pneumonia. Genes Immun 2021;22:141-60. [PMID: 34140652 DOI: 10.1038/s41435-021-00140-w] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
61 Friedman AN, Guirguis J, Kapoor R, Gupta S, Leaf DE, Timsina LR; STOP-COVID Investigators. Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID-19 in the US. Obesity (Silver Spring) 2021. [PMID: 34109768 DOI: 10.1002/oby.23245] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
62 Quiroga SA, Hernández C, Castañeda S, Jimenez P, Vega L, Gomez M, Martinez D, Ballesteros N, Muñoz M, Cifuentes C, Sierra N, Flórez C, Paniz-Mondolfi A, Ramírez JD. Contrasting SARS-CoV-2 RNA copies and clinical symptoms in a large cohort of Colombian patients during the first wave of the COVID-19 pandemic. Ann Clin Microbiol Antimicrob 2021;20:39. [PMID: 34030702 DOI: 10.1186/s12941-021-00445-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
63 Wilden JJ, Jacob JC, Ehrhardt C, Ludwig S, Boergeling Y. Altered Signal Transduction in the Immune Response to Influenza Virus and S. pneumoniae or S. aureus Co-Infections. Int J Mol Sci 2021;22:5486. [PMID: 34067487 DOI: 10.3390/ijms22115486] [Reference Citation Analysis]
64 Cezard A, Guillon A, Si-Tahar M. [Identification of a metabolic immune regulator in the host that protects against influenzal pneumonia]. Rev Mal Respir 2021;38:567-71. [PMID: 34024644 DOI: 10.1016/j.rmr.2021.05.003] [Reference Citation Analysis]
65 Bersanelli M, Giannarelli D, De Giorgi U, Pignata S, Di Maio M, Clemente A, Verzoni E, Giusti R, Di Napoli M, Aprile G, Ermacora P, Catino A, Scotti V, Mazzoni F, Guglielmini PF, Veccia A, Maruzzo M, Rossi E, Grossi F, Casadei C, Ficorella C, Montesarchio V, Verderame F, Rizzo M, Guaitoli G, Fratino L, Accettura C, Mencoboni M, Zustovich F, Baldessari C, Cinieri S, Camerini A, Laera L, Sorarù M, Zucali PA, Guadalupi V, Leonardi F, Tiseo M, Tognetto M, Di Costanzo F, Pinto C, Negrini G, Russo A, Migliorino MR, Filetti M, Buti S; FICOG group (Federation of Italian Cooperative Oncology Groups). INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a multicenter prospective observational study (INVIDIa-2). J Immunother Cancer 2021;9:e002619. [PMID: 34016723 DOI: 10.1136/jitc-2021-002619] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
66 Cheong CW, Chen CL, Li CH, Seak CJ, Tseng HJ, Hsu KH, Ng CJ, Chien CY. Two-stage prediction model for in-hospital mortality of patients with influenza infection. BMC Infect Dis 2021;21:451. [PMID: 34011298 DOI: 10.1186/s12879-021-06169-6] [Reference Citation Analysis]
67 Shi Y, Chen W, Zeng M, Shen G, Sun C, Liu G, Gong H, Wang C, Ge M, Xu J, Wang L, Lu A, Lu G, Zhai X. Clinical features and risk factors for severe influenza in children: A study from multiple hospitals in Shanghai. Pediatr Neonatol 2021;62:428-36. [PMID: 34103261 DOI: 10.1016/j.pedneo.2021.05.002] [Reference Citation Analysis]
68 Fahim M, AbdElGawad B, Hassan H, Naguib A, Ahmed E, Afifi S, Abu ElSood H, Mohsen A. Epidemiology and outcome of influenza-associated infections among hospitalized patients with acute respiratory infections, Egypt national surveillance system, 2016-2019. Influenza Other Respir Viruses 2021;15:589-98. [PMID: 33960675 DOI: 10.1111/irv.12867] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Bohmwald K, Andrade CA, Kalergis AM. Contribution of Pro-Inflammatory Molecules Induced by Respiratory Virus Infections to Neurological Disorders. Pharmaceuticals (Basel) 2021;14:340. [PMID: 33917837 DOI: 10.3390/ph14040340] [Reference Citation Analysis]
70 Beach TG, Sue LI, Intorcia AJ, Glass MJ, Walker JE, Arce R, Nelson CM, Serrano GE. Acute Brain Ischemia, Infarction and Hemorrhage in Subjects Dying with or Without Autopsy-Proven Acute Pneumonia. medRxiv 2021:2021. [PMID: 33791728 DOI: 10.1101/2021.03.22.21254139] [Reference Citation Analysis]
71 Donnino MW, Moskowitz A, Thompson GS, Heydrick SJ, Pawar RD, Berg KM, Mehta S, Patel PV, Grossestreuer AV. Comparison between Patients Hospitalized with Influenza and COVID-19 at a Tertiary Care Center. J Gen Intern Med 2021;36:1689-95. [PMID: 33738759 DOI: 10.1007/s11606-021-06647-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
72 Póvoa P, Coelho L, Salluh J. When should we use corticosteroids in severe community-acquired pneumonia? Curr Opin Infect Dis 2021;34:169-74. [PMID: 33394726 DOI: 10.1097/QCO.0000000000000709] [Reference Citation Analysis]
73 Bai Y, Tao X. Comparison of COVID-19 and influenza characteristics. J Zhejiang Univ Sci B 2021;22:87-98. [PMID: 33615750 DOI: 10.1631/jzus.B2000479] [Reference Citation Analysis]
74 Linfield DT, Raduka A, Aghapour M, Rezaee F. Airway tight junctions as targets of viral infections. Tissue Barriers 2021;9:1883965. [PMID: 33632074 DOI: 10.1080/21688370.2021.1883965] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
75 Tong DM, Zhou YT, Wang YW. COVID-19-Associated Acute Brain Dysfunction Related to Sepsis. J Clin Med Res 2021;13:82-91. [PMID: 33747322 DOI: 10.14740/jocmr4437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Fragkou PC, Moschopoulos CD, Karofylakis E, Kelesidis T, Tsiodras S. Update in Viral Infections in the Intensive Care Unit. Front Med (Lausanne) 2021;8:575580. [PMID: 33708775 DOI: 10.3389/fmed.2021.575580] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
77 Harper A, Vijayakumar V, Ouwehand AC, Ter Haar J, Obis D, Espadaler J, Binda S, Desiraju S, Day R. Viral Infections, the Microbiome, and Probiotics. Front Cell Infect Microbiol 2020;10:596166. [PMID: 33643929 DOI: 10.3389/fcimb.2020.596166] [Cited by in Crossref: 2] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
78 Imran S, Ahmadi S, Kerman K. Electrochemical Biosensors for the Detection of SARS-CoV-2 and Other Viruses. Micromachines (Basel) 2021;12:174. [PMID: 33578979 DOI: 10.3390/mi12020174] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
79 Cheng P, Wu H, Yang J, Song X, Xu M, Li B, Zhang J, Qin M, Zhou C, Zhou X. Pneumonia scoring systems for severe COVID-19: which one is better. Virol J 2021;18:33. [PMID: 33568204 DOI: 10.1186/s12985-021-01502-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
80 Seeherman S, Suzuki YJ. Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis. Int J Mol Sci 2021;22:1659. [PMID: 33562193 DOI: 10.3390/ijms22041659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
81 Ashar HK, Pulavendran S, Rudd JM, Maram P, Achanta M, Chow VTK, Malayer JR, Snider TA, Teluguakula N. Administration of a CXC Chemokine Receptor 2 (CXCR2) Antagonist, SCH527123, Together with Oseltamivir Suppresses NETosis and Protects Mice from Lethal Influenza and Piglets from Swine-Influenza Infection. Am J Pathol 2021;191:669-85. [PMID: 33453177 DOI: 10.1016/j.ajpath.2020.12.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Li X, Berg NK, Mills T, Zhang K, Eltzschig HK, Yuan X. Adenosine at the Interphase of Hypoxia and Inflammation in Lung Injury. Front Immunol 2020;11:604944. [PMID: 33519814 DOI: 10.3389/fimmu.2020.604944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
83 Beach TG, Russell A, Sue LI, Intorcia AJ, Glass MJ, Walker JE, Arce R, Nelson CM, Hidalgo T, Chiarolanza G, Mariner M, Scroggins A, Pullen J, Souders L, Sivananthan K, Carter N, Saxon-LaBelle M, Hoffman B, Garcia A, Callan M, Fornwalt BE, Carew J, Filon J, Cutler B, Papa J, Curry JR, Oliver J, Shprecher D, Atri A, Belden C, Shill HA, Driver-Dunckley E, Mehta SH, Adler CH, Haarer CF, Ruhlen T, Torres M, Nguyen S, Schmitt D, Fietz M, Lue LF, Walker DG, Mizgerd JP, Serrano GE. Increased Risk of Autopsy-Proven Pneumonia with Sex, Season and Neurodegenerative Disease. medRxiv 2021:2021. [PMID: 33442709 DOI: 10.1101/2021.01.07.21249410] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
84 Rezkalla SH, Kloner RA. Viral myocarditis: 1917-2020: From the Influenza A to the COVID-19 pandemics. Trends Cardiovasc Med 2021;31:163-9. [PMID: 33383171 DOI: 10.1016/j.tcm.2020.12.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
85 Murillo-Zamora E, Mendoza-Cano O, Delgado-Enciso I, Guzmán-Esquivel J. National retrospective cohort study to identify risk factors for in-hospital 30-day lethality in laboratory-confirmed cases of influenza. Rev Clin Esp (Barc) 2021;221:76-85. [PMID: 33998492 DOI: 10.1016/j.rceng.2020.05.013] [Reference Citation Analysis]
86 Ryabkova VA, Churilov LP, Shoenfeld Y. Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned. Clin Immunol. 2021;223:108652. [PMID: 33333256 DOI: 10.1016/j.clim.2020.108652] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
87 Shen H, Qu D, Na W, Liu S, Huang S, Hui Y. Comparison of the OI and PaO2 /FiO2 score in evaluating PARDS requiring mechanical ventilation. Pediatr Pulmonol 2021;56:1182-8. [PMID: 33289279 DOI: 10.1002/ppul.25194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
88 Liu M, Li W, Song F, Zhang L, Sun X. Silencing of lncRNA MIAT alleviates LPS-induced pneumonia via regulating miR-147a/NKAP/NF-κB axis. Aging (Albany NY) 2020;13:2506-18. [PMID: 33318298 DOI: 10.18632/aging.202284] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
89 Perry MA. Understanding influenza and the complications it causes. Practice Nursing 2020;31:S10-4. [DOI: 10.12968/pnur.2020.31.sup12.s10] [Reference Citation Analysis]
90 Wang Y, Ru Y, Zhuo G, Sheng M, Wang S, Ma J, Zhou C, Sun X, Zeng Y, Zhang Y, Li H, Lu Z, Wu D, Wu M. Investigation of the Potential Mechanism Governing the Effect of the Shen Zhu San on COVID-19 by Network Pharmacology. Evid Based Complement Alternat Med 2020;2020:8468303. [PMID: 33224256 DOI: 10.1155/2020/8468303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Zhao Y, Yu C, Ni W, Shen H, Qiu M, Zhao Y. Peripheral blood inflammatory markers in predicting prognosis in patients with COVID-19. Some differences with influenza A. J Clin Lab Anal 2021;35:e23657. [PMID: 33225517 DOI: 10.1002/jcla.23657] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
92 Forbester JL, Humphreys IR. Genetic influences on viral-induced cytokine responses in the lung. Mucosal Immunol 2021;14:14-25. [PMID: 33184476 DOI: 10.1038/s41385-020-00355-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
93 Melo EM, Del Sarto J, Vago JP, Tavares LP, Rago F, Gonçalves APF, Machado MG, Aranda-Pardos I, Valiate BVS, Cassali GD, Pinho V, Sousa LP, A-Gonzalez N, Campagnole-Santos MJ, Bader M, Santos RAS, Machado AV, Ludwig S, Teixeira MM. Relevance of angiotensin-(1-7) and its receptor Mas in pneumonia caused by influenza virus and post-influenza pneumococcal infection. Pharmacol Res 2021;163:105292. [PMID: 33171305 DOI: 10.1016/j.phrs.2020.105292] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
94 Beović B, Doušak M, Ferreira-Coimbra J, Nadrah K, Rubulotta F, Belliato M, Berger-Estilita J, Ayoade F, Rello J, Erdem H. Antibiotic use in patients with COVID-19: a 'snapshot' Infectious Diseases International Research Initiative (ID-IRI) survey. J Antimicrob Chemother 2020;75:3386-90. [PMID: 32766706 DOI: 10.1093/jac/dkaa326] [Cited by in Crossref: 53] [Cited by in F6Publishing: 85] [Article Influence: 26.5] [Reference Citation Analysis]
95 Gopal R, Marinelli MA, Alcorn JF. Immune Mechanisms in Cardiovascular Diseases Associated With Viral Infection. Front Immunol 2020;11:570681. [PMID: 33193350 DOI: 10.3389/fimmu.2020.570681] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
96 Yang F, Yue R, Luo X, Liu R, Huang X. Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients. Front Pharmacol 2020;11:543718. [PMID: 33178011 DOI: 10.3389/fphar.2020.543718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
97 Nishioka K, Kyo M, Nakaya T, Shime N. Proteins produced by Streptococcus species in the lower respiratory tract can modify antiviral responses against influenza virus in respiratory epithelial cells. Microbes Infect 2021;23:104764. [PMID: 33038518 DOI: 10.1016/j.micinf.2020.09.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
98 Qu J, Chang LK, Tang X, Du Y, Yang X, Liu X, Han P, Xue Y. Clinical characteristics of COVID-19 and its comparison with influenza pneumonia. Acta Clin Belg 2020;75:348-56. [PMID: 32723027 DOI: 10.1080/17843286.2020.1798668] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
99 Rioux M, McNeil M, Francis ME, Dawe N, Foley M, Langley JM, Kelvin AA. The Power of First Impressions: Can Influenza Imprinting during Infancy Inform Vaccine Design? Vaccines (Basel) 2020;8:E546. [PMID: 32961707 DOI: 10.3390/vaccines8030546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
100 Monpara JD, Sodha SJ, Gupta PK. COVID-19 associated complications and potential therapeutic targets. Eur J Pharmacol. 2020;886:173548. [PMID: 32926918 DOI: 10.1016/j.ejphar.2020.173548] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
101 Chen L, Han X, Li Y, Zhang C, Xing X. Derivation and validation of a prediction rule for mortality of patients with respiratory virus-related pneumonia (RV-p score). Ther Adv Respir Dis 2020;14:1753466620953780. [PMID: 32912054 DOI: 10.1177/1753466620953780] [Reference Citation Analysis]
102 Klomp M, Ghosh S, Mohammed S, Nadeem Khan M. From virus to inflammation, how influenza promotes lung damage. J Leukoc Biol 2021;110:115-22. [PMID: 32895987 DOI: 10.1002/JLB.4RU0820-232R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
103 McCartney SA, Kachikis A, Huebner EM, Walker CL, Chandrasekaran S, Adams Waldorf KM. Obesity as a contributor to immunopathology in pregnant and non-pregnant adults with COVID-19. Am J Reprod Immunol 2020;84:e13320. [PMID: 32779790 DOI: 10.1111/aji.13320] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
104 Percopo CM, Ma M, Mai E, Redes JL, Kraemer LS, Minai M, Moore IN, Druey KM, Rosenberg HF. Alternaria alternata Accelerates Loss of Alveolar Macrophages and Promotes Lethal Influenza A Infection. Viruses 2020;12:E946. [PMID: 32867061 DOI: 10.3390/v12090946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
105 Yoon JG, Noh JY, Choi WS, Lee J, Lee JS, Wie SH, Kim YK, Jeong HW, Kim SW, Park KH, Song JY, Cheong HJ, Kim WJ. A comparison of epidemiology and clinical outcomes between influenza A H1N1pdm09 and H3N2 based on multicenter surveillance from 2014 to 2018 in South Korea. Influenza Other Respir Viruses 2021;15:99-109. [PMID: 32844596 DOI: 10.1111/irv.12795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
106 Swieboda D, Littauer EQ, Beaver JT, Mills LK, Bricker KM, Esser ES, Antao OQ, Williams DT, Skountzou I. Pregnancy Downregulates Plasmablast Metabolic Gene Expression Following Influenza Without Altering Long-Term Antibody Function. Front Immunol 2020;11:1785. [PMID: 32922392 DOI: 10.3389/fimmu.2020.01785] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
107 Kato M, Saisho Y, Tanaka H, Bando T. Effect of peramivir on respiratory symptom improvement in patients with influenza virus infection and pre-existing chronic respiratory disease: Findings of a randomized, open-label study. Influenza Other Respir Viruses 2021;15:132-41. [PMID: 32677375 DOI: 10.1111/irv.12788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
108 Yu J, Sun X, Goie JYG, Zhang Y. Regulation of Host Immune Responses against Influenza A Virus Infection by Mitogen-Activated Protein Kinases (MAPKs). Microorganisms 2020;8:E1067. [PMID: 32709018 DOI: 10.3390/microorganisms8071067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
109 Stubbs BJ, Koutnik AP, Goldberg EL, Upadhyay V, Turnbaugh PJ, Verdin E, Newman JC. Investigating Ketone Bodies as Immunometabolic Countermeasures against Respiratory Viral Infections. Med (N Y) 2020;1:43-65. [PMID: 32838361 DOI: 10.1016/j.medj.2020.06.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
110 Murillo-Zamora E, Mendoza-Cano O, Delgado-Enciso I, Guzmán-Esquivel J. National retrospective cohort study to identify risk factors for in-hospital 30-day lethality in laboratory-confirmed cases of influenza. Rev Clin Esp 2020:S0014-2565(20)30177-6. [PMID: 32674849 DOI: 10.1016/j.rce.2020.05.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
111 Arastehfar A, Carvalho A, van de Veerdonk FL, Jenks JD, Koehler P, Krause R, Cornely OA, S Perlin D, Lass-Flörl C, Hoenigl M. COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment. J Fungi (Basel) 2020;6:E91. [PMID: 32599813 DOI: 10.3390/jof6020091] [Cited by in Crossref: 83] [Cited by in F6Publishing: 74] [Article Influence: 41.5] [Reference Citation Analysis]
112 Verweij PE, Rijnders BJA, Brüggemann RJM, Azoulay E, Bassetti M, Blot S, Calandra T, Clancy CJ, Cornely OA, Chiller T, Depuydt P, Giacobbe DR, Janssen NAF, Kullberg BJ, Lagrou K, Lass-Flörl C, Lewis RE, Liu PW, Lortholary O, Maertens J, Martin-Loeches I, Nguyen MH, Patterson TF, Rogers TR, Schouten JA, Spriet I, Vanderbeke L, Wauters J, van de Veerdonk FL. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med 2020;46:1524-35. [PMID: 32572532 DOI: 10.1007/s00134-020-06091-6] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 42.5] [Reference Citation Analysis]
113 Huang XB, Yuan L, Ye CX, Zhu X, Lin CJ, Zhang DM, He KS, Niu RX, Cao KY, Xu L. Epidemiological characteristics of respiratory viruses in patients with acute respiratory infections during 2009-2018 in southern China. Int J Infect Dis 2020;98:21-32. [PMID: 32562851 DOI: 10.1016/j.ijid.2020.06.051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
114 Filardo S, Di Pietro M, Mastromarino P, Sessa R. Therapeutic potential of resveratrol against emerging respiratory viral infections. Pharmacol Ther 2020;214:107613. [PMID: 32562826 DOI: 10.1016/j.pharmthera.2020.107613] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 15.5] [Reference Citation Analysis]
115 Liu Z, Ying Y. The Inhibitory Effect of Curcumin on Virus-Induced Cytokine Storm and Its Potential Use in the Associated Severe Pneumonia. Front Cell Dev Biol 2020;8:479. [PMID: 32596244 DOI: 10.3389/fcell.2020.00479] [Cited by in Crossref: 41] [Cited by in F6Publishing: 59] [Article Influence: 20.5] [Reference Citation Analysis]
116 Chu SE, Seak CJ, Su TH, Chaou CH, Tseng HJ, Li CH. Prognostic accuracy of SIRS criteria and qSOFA score for in-hospital mortality among influenza patients in the emergency department. BMC Infect Dis 2020;20:385. [PMID: 32471385 DOI: 10.1186/s12879-020-05102-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
117 Mansur JL, Tajer C, Mariani J, Inserra F, Ferder L, Manucha W. Vitamin D high doses supplementation could represent a promising alternative to prevent or treat COVID-19 infection. Clin Investig Arterioscler 2020;32:267-77. [PMID: 32718670 DOI: 10.1016/j.arteri.2020.05.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
118 Edwards BL, Dorfman D. High-risk Pediatric Emergencies. Emergency Medicine Clinics of North America 2020;38:383-400. [DOI: 10.1016/j.emc.2020.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
119 Foust AM, Winant AJ, Chu WC, Das KM, Phillips GS, Lee EY. Pediatric SARS, H1N1, MERS, EVALI, and Now Coronavirus Disease (COVID-19) Pneumonia: What Radiologists Need to Know. AJR Am J Roentgenol 2020;215:736-44. [PMID: 32352308 DOI: 10.2214/AJR.20.23267] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
120 Darden DB, Hawkins RB, Larson SD, Iovine NM, Prough DS, Efron PA. The Clinical Presentation and Immunology of Viral Pneumonia and Implications for Management of Coronavirus Disease 2019. Crit Care Explor 2020;2:e0109. [PMID: 32426751 DOI: 10.1097/CCE.0000000000000109] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
121 Jin L, Ying ZH, Yu CH, Zhang HH, Yu WY, Wu XN. Isofraxidin ameliorated influenza viral inflammation in rodents via inhibiting platelet aggregation. Int Immunopharmacol 2020;84:106521. [PMID: 32315950 DOI: 10.1016/j.intimp.2020.106521] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
122 Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, Bhattoa HP. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients. 2020;12. [PMID: 32252338 DOI: 10.3390/nu12040988] [Cited by in Crossref: 672] [Cited by in F6Publishing: 558] [Article Influence: 336.0] [Reference Citation Analysis]
123 Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, Bhattoa HP. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths.Nutrients. 2020;12. [PMID: 32252338 DOI: 10.20944/preprints202003.0235.v2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 9.0] [Reference Citation Analysis]
124 Nasser MI, Zhu S, Huang H, Zhao M, Wang B, Ping H, Geng Q, Zhu P. Macrophages: First guards in the prevention of cardiovascular diseases. Life Sci 2020;250:117559. [PMID: 32198051 DOI: 10.1016/j.lfs.2020.117559] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
125 Taye B, Chen H, Yeo DS, Seah SG, Wong MS, Sugrue RJ, Tan BH. A System Based-Approach to Examine Host Response during Infection with Influenza A Virus Subtype H7N9 in Human and Avian Cells. Cells 2020;9:E448. [PMID: 32075271 DOI: 10.3390/cells9020448] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
126 Yu WY, Li L, Wu F, Zhang HH, Fang J, Zhong YS, Yu CH. Moslea Herba flavonoids alleviated influenza A virus-induced pulmonary endothelial barrier disruption via suppressing NOX4/NF-κB/MLCK pathway. J Ethnopharmacol 2020;253:112641. [PMID: 32017949 DOI: 10.1016/j.jep.2020.112641] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
127 Cillóniz C, Menéndez R, García-Vidal C, Péricas JM, Torres A. Defining Community-Acquired Pneumonia as a Public Health Threat: Arguments in Favor from Spanish Investigators. Med Sci (Basel) 2020;8:E6. [PMID: 31991843 DOI: 10.3390/medsci8010006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
128 Han Q, Wen X, Wang L, Han X, Shen Y, Cao J, Peng Q, Xu J, Zhao L, He J, Yuan H. Role of hematological parameters in the diagnosis of influenza virus infection in patients with respiratory tract infection symptoms. J Clin Lab Anal 2020;34:e23191. [PMID: 31901184 DOI: 10.1002/jcla.23191] [Cited by in Crossref: 12] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
129 Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dubé M, Talbot PJ. Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Viruses 2019;12:E14. [PMID: 31861926 DOI: 10.3390/v12010014] [Cited by in Crossref: 411] [Cited by in F6Publishing: 364] [Article Influence: 137.0] [Reference Citation Analysis]
130 Misra RS, Nayak JL. The Importance of Vaccinating Children and Pregnant Women against Influenza Virus Infection. Pathogens 2019;8:E265. [PMID: 31779153 DOI: 10.3390/pathogens8040265] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
131 Yang Z, Bedugnis A, Levinson S, DiNubile M, Stossel T, Lu Q, Kobzik L. Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza. F1000Res 2019;8:1860. [PMID: 31824672 DOI: 10.12688/f1000research.21082.2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
132 Yang Z, Bedugnis A, Levinson S, DiNubile M, Stossel T, Lu Q, Kobzik L. Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza. F1000Res 2019;8:1860. [PMID: 31824672 DOI: 10.12688/f1000research.21082.2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
133 [DOI: 10.1101/2020.08.19.20163857] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]